P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW.

Detalles Bibliográficos
Autores principales: Gundesen, Michael, Schjesvold, Fredrik, Vangsted, Annette, Helleberg, Carsten, Haukås, Einar, Silkjær, Trine, Todorescu, Elena, Amdi Jensen, Bo, Slørdahl, Tobias S., Thor Asmussen, Jon, Nahi, Hareth, Waage, Anders, Abildgaard, Niels, Lund, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431145/
http://dx.doi.org/10.1097/01.HS9.0000970580.01478.5b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431145/
http://dx.doi.org/10.1097/01.HS9.0000970580.01478.5b

Ejemplares similares